F. de Waard

3.1k total citations
63 papers, 2.4k citations indexed

About

F. de Waard is a scholar working on Oncology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, F. de Waard has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 19 papers in Genetics and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in F. de Waard's work include Cancer Risks and Factors (25 papers), Global Cancer Incidence and Screening (13 papers) and Estrogen and related hormone effects (13 papers). F. de Waard is often cited by papers focused on Cancer Risks and Factors (25 papers), Global Cancer Incidence and Screening (13 papers) and Estrogen and related hormone effects (13 papers). F. de Waard collaborates with scholars based in Netherlands, United States and United Kingdom. F. de Waard's co-authors include Elwine Halewijn, H.J.A. Collette, Jan J. Rombach, Nicholas Day, D. Trichopoulos, Jantien van Berkel, Cora Honing, Jan Cornelis, Minoru Yoshida and Kunio Aoki and has published in prestigious journals such as The Lancet, American Journal of Clinical Nutrition and JNCI Journal of the National Cancer Institute.

In The Last Decade

F. de Waard

61 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. de Waard Netherlands 24 1.5k 522 512 369 343 63 2.4k
Rosemarie Hanisch United States 15 960 0.7× 487 0.9× 430 0.8× 226 0.6× 310 0.9× 16 2.0k
L N Kolonel United States 20 628 0.4× 596 1.1× 542 1.1× 264 0.7× 282 0.8× 22 2.5k
P.A.H. van Noord Netherlands 23 660 0.5× 458 0.9× 311 0.6× 176 0.5× 224 0.7× 36 1.9k
RK Ross United States 12 627 0.4× 280 0.5× 438 0.9× 258 0.7× 105 0.3× 13 1.8k
A. Volovics Netherlands 23 846 0.6× 296 0.6× 376 0.7× 266 0.7× 147 0.4× 37 2.5k
IS Fentiman United Kingdom 26 1.1k 0.8× 223 0.4× 599 1.2× 997 2.7× 119 0.3× 54 2.3k
Libby M. Morimoto United States 20 938 0.6× 373 0.7× 254 0.5× 270 0.7× 157 0.5× 68 1.7k
Kara L. Cushing‐Haugen United States 25 511 0.3× 381 0.7× 414 0.8× 362 1.0× 134 0.4× 59 2.5k
Gabriela Torres-Mejı́a Mexico 25 745 0.5× 392 0.8× 397 0.8× 333 0.9× 112 0.3× 82 1.7k
Matti A. Rookus Netherlands 30 1.0k 0.7× 384 0.7× 1.5k 2.9× 729 2.0× 196 0.6× 65 2.7k

Countries citing papers authored by F. de Waard

Since Specialization
Citations

This map shows the geographic impact of F. de Waard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. de Waard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. de Waard more than expected).

Fields of papers citing papers by F. de Waard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. de Waard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. de Waard. The network helps show where F. de Waard may publish in the future.

Co-authorship network of co-authors of F. de Waard

This figure shows the co-authorship network connecting the top 25 collaborators of F. de Waard. A scholar is included among the top collaborators of F. de Waard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. de Waard. F. de Waard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waard, F. de & J.H.H. Thijssen. (2005). Hormonal aspects in the causation of human breast cancer: Epidemiological hypotheses reviewed, with special reference to nutritional status and first pregnancy. The Journal of Steroid Biochemistry and Molecular Biology. 97(5). 451–458. 17 indexed citations
2.
Waard, F. de, et al.. (2000). A case of twin-to-twin transfusion in 1617. The Lancet. 356(9232). 847–848. 11 indexed citations
3.
Meyskens, FL, Marianne Gerber, F. de Waard, et al.. (2000). WHO consensus conference on diet and cancer. European Journal of Cancer Prevention. 9(3). 213–216. 4 indexed citations
4.
Waard, F. de, et al.. (1996). Endometrial cancer in a cohort screened for breast cancer. European Journal of Cancer Prevention. 5(2). 99–104. 12 indexed citations
5.
Tonkelaar, Isolde den & F. de Waard. (1996). Regularity and length of menstrual cycles in women aged 41–46 in relation to breast cancer risk: Results from the DOM-project. Breast Cancer Research and Treatment. 38(3). 253–258. 34 indexed citations
6.
Waard, F. de, et al.. (1995). Urinary nicotine metabolite excretion and lung cancer risk in a female cohort. British Journal of Cancer. 72(3). 788–791. 12 indexed citations
7.
Waard, F. de, et al.. (1995). Urinary cotinine and lung cancer risk in a female cohort. British Journal of Cancer. 72(3). 784–787. 33 indexed citations
8.
Waard, F. de, et al.. (1994). Breast cancer screening in the framework of the Europe against Cancer programme. European Journal of Cancer Prevention. 3(Supplement). 3–6. 14 indexed citations
9.
Tonkelaar, Isolde den, et al.. (1994). A prospective study on obesity and subcutaneous fat patterning in relation to breast cancer in post-menopausal women participating in the DOM project. British Journal of Cancer. 69(2). 352–357. 30 indexed citations
10.
Waard, F. de, et al.. (1993). A feasibility study on weight reduction in obese postmenopausal breast cancer patients. European Journal of Cancer Prevention. 2(3). 233–238. 61 indexed citations
11.
Howe, Geoffrey R., P Ghadirian, H. Bas Bueno de Mesquita, et al.. (1992). A collaborative case‐control study of nutrient intake and pancreatic cancer within the search programme. International Journal of Cancer. 51(3). 365–372. 108 indexed citations
12.
Waard, F. de. (1992). Preventive intervention in breast cancer, but when?. European Journal of Cancer Prevention. 1(6). 395–400. 25 indexed citations
13.
Waard, F. de. (1991). Endocrine aspects of cancer: An epidemiological approach. The Journal of Steroid Biochemistry and Molecular Biology. 40(1-3). 15–19. 6 indexed citations
14.
Waard, F. de, et al.. (1988). Breast cancer screening, with particular reference to the concept of ‘high risk’ groups. Breast Cancer Research and Treatment. 11(2). 125–132. 4 indexed citations
15.
Waard, F. de & D. Trichopoulos. (1988). A unifying concept of the aetiology of breast cancer. International Journal of Cancer. 41(5). 666–669. 144 indexed citations
16.
Waard, F. de & D.Y. Wang. (1988). Epidemiology and prevention: Workshop report. European Journal of Cancer and Clinical Oncology. 24(1). 45–48. 6 indexed citations
17.
Hill, Peter, et al.. (1988). Peptide and steroid hormones in subjects at different risk for diet-related diseases. American Journal of Clinical Nutrition. 48(3). 782–786. 5 indexed citations
18.
Hill, Peter, L. Garbaczewski, H. P. F. Koppeschaar, Jos H.H. Thijssen, & F. de Waard. (1987). Glucagon and insulin response to meals in non-obese and obese Dutch women. Clinica Chimica Acta. 165(2-3). 253–261. 2 indexed citations
19.
Waard, F. de, et al.. (1968). Steroid hormone excretion pattern in women with endometrial carcinoma. Cancer. 22(5). 988–993. 17 indexed citations
20.
Thijssen, J.H.H., F. de Waard, & A Wiersinga. (1967). HYDROCORTISONE-PRODUCTION RATES IN AFRICANS. The Lancet. 289(7494). 814–816. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026